48 search results for: asthma

ERS 2024 | Pediatric Severe <b>Asthma</b>: Is Clinical Remission Possible?
expert video

ERS 2024 | Pediatric Severe Asthma: Is Clinical Remission Possible?

Pulmonology
Watch as Leonard Bacharier, MD, and Sharon Dell, MD, FRCPC, discuss the concept of clinical remission in pediatric severe asthma.
View more
How Can Poor Lung Function Impact <b>Asthma</b> Burden in Adult Patients?
videoanimation

How Can Poor Lung Function Impact Asthma Burden in Adult Patients?

Pulmonology
Explore the impact of impaired lung function on the burden faced by adults living with asthma.
View more
EAACI 2024 Emerging Definitions of Clinical Remission and Achieving Clinical Remission With Biologics for Patients With <b>Asthma</b>
expert video

EAACI 2024 Emerging Definitions of Clinical Remission and Achieving Clinical Remission With Biologics for Patients With Asthma

Pulmonology
Join Professor Vibeke Backer for a presentation on clinical remission in asthma and achieving remission with biologics for patients with uncontrolled asthma.
View more
Pediatric <b>Asthma</b> Trajectory and Clinical Remission
expert video

Pediatric Asthma Trajectory and Clinical Remission

Type 2 Inflammation
Join Dr. Leonard Bacharier as he discusses the definition of clinical remission in pediatric asthma and how it can represent a potential target in pediatric asthma management.
View more
ADVENT On Air | What Is the Future Outlook for Remission in Pediatric Severe <b>Asthma</b>?
Podcast

ADVENT On Air | What Is the Future Outlook for Remission in Pediatric Severe Asthma?

Pulmonology
Join Drs. Len Bacharier and Sharon Dell as they highlight the natural course of pediatric asthma progression over time.
View more
Lung Function Assessment Is a Fundamental Component of Optimal <b>Asthma</b> Care
videoanimation

Lung Function Assessment Is a Fundamental Component of Optimal Asthma Care

Pulmonology
Learn more about the importance of lung function assessment in optimizing care for adult and pediatric patients with asthma.
View more
How Can Poor Lung Function Impact <b>Asthma</b> Burden in Pediatric Patients?
videoanimation

How Can Poor Lung Function Impact Asthma Burden in Pediatric Patients?

Pulmonology
Learn about the importance of lung function assessment in pediatric asthma patients.
View more
Mucus Plugging as a Potential Target in <b>Asthma</b> Management
expert video

Mucus Plugging as a Potential Target in Asthma Management

Type 2 Inflammation
Join Dr. Celeste Porsbjerg as she explores the mechanisms underlying mucus plugging development as mucociliary clearance. She explains how type 2 cytokines—particularly IL-13—impair this clearance mechanism, leading to mucus plugging, and worsened asthma outcomes.
View more
Screen depicting a mucus plug in the airways
videoanimation

A view into the Airway: The Pathophysiology and Clinical Relevance of Mucus Plugs in Asthma

Pulmonology
Explore the role of type 2 inflammation in the production of mucus plugs in asthma and the effects these plugs can have on patients.
View more
Role of Type 2 Cytokines in <b>Asthma</b> and COPD
expert video

Role of Type 2 Cytokines in Asthma and COPD

Type 2 Inflammation
Dr Mario Castro explains how type 2 cytokines play a crucial role in airway remodeling and inflammation in asthma and COPD, impacting patient outcomes.
View more
ADVENT On Air | The Road Ahead: Achieving Remission for ​Patients With <b>Asthma</b>
Podcast

ADVENT On Air | The Road Ahead: Achieving Remission for ​Patients With Asthma

Pulmonology
Join Professors Klaus Rabe and Ian Pavord as they discuss the importance of on-treatment clinical remission as a goal in asthma management.
View more
ATS 2024 | Type 2 Inflammation in the Pathophysiology of <b>Asthma</b> and COPD: What Is It and How Does It Impact Patients?
expert video

ATS 2024 | Type 2 Inflammation in the Pathophysiology of Asthma and COPD: What Is It and How Does It Impact Patients?

Pulmonology
Join leading experts for an educational symposium where they delve into the clinical consequences and real-world patient burden of type 2 inflammation in asthma and COPD.
View more

ADVENT is a global medical education non-promotional program by Sanofi and Regeneron. This website is intended only for duly authenticated healthcare professionals in Algeria, Argentina, Australia, Austria, Bahrain, Belgium, Brazil, Bulgaria, Canada, Chile, China, Colombia, Costa Rica, Croatia, Czech Republic, Denmark, Dominican Republic, Ecuador, Egypt, Estonia, Finland, France, Germany, Greece, Guatemala, Hong Kong, Hungary, Iceland, India, Israel, Italy, Japan, Kuwait, Latvia, Lebanon, Lithuania, Macau, Malaysia, Norway, Oman, Panama, Peru, Poland, Portugal, Qatar, Romania, Saudi Arabia, Singapore, Slovenia, South Africa, South Korea, Spain, Sudan, Sweden, Switzerland, Taiwan, Thailand, The Netherlands, Turkey, United Arab Emirates, or the United States of America.

For healthcare professionals in Algeria: Please read the additional Terms of Use.

Sanofi | Regeneron Logo

© 2025 Sanofi and Regeneron Pharmaceuticals, Inc.

All rights reserved.
MAT-GLB-2302957 v3.0 11/2023

All Rights Reserved.

Sanofi and Regeneron are global leaders in pharmaceutical development, each with a long history of supporting frontline physicians to improve human health and reduce the burden of disease. Driven by the same commitment to patients and their families, Sanofi and Regeneron have partnered to take on type 2 inflammation and the range of chronic conditions in which excessive inflammation plays a role.

Country/region: AlgeriaChange country/region